A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001)

NCT00559182 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: Comparator: MK-8033
DRUG: Comparator: MK-8033 +/- omeprazole

Sponsor

Merck Sharp & Dohme LLC